Stock Taper
SCREENER COMPARE ANY 2 STOCKS
RANI
RANI THERAPEUTICS HOLDINGS, INC.
NASDAQ
$0.84
▼ DOWN 1.66% (-0.01)

KEY STATISTICS

Market Cap$54.87 M
52w High$3.87
52w Low$0.44
Dividend Yield—
Frequency—
P/E-2.05
Volume371.27K
Shares Out.65.32M

COMPANY

LEADERSHIP

Talat Imran
CHIEF EXECUTIVE
Talat Imran

COMPENSATION 2026

Salary$198,325
Stock Awards$0
Incentive Plan Pay$351,600
All Other Comp.$0
Total$1,052,101

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 30, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
70

PRICE TARGET

Target High$28.00
Target Low$9.00
Target Median$10.00
Target Consensus$15.67

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.$1.28M
NOV
5
THU

PRICE

$0.84 ▼ DOWN 1.66% (−$0.01)
$0.84$0.85$0.859:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM0.84

About Rani Therapeutics Holdings, Inc.

https://www.ranitherapeutics.com ↗

Rani Therapeutics develops oral biologics using its RaniPill platform, with a pipeline including treatments for neuroendocrine tumors, psoriatic arthritis, osteoporosis, growth hormone deficiency, hypoparathyroidism, and type 2 diabetes.

INDUSTRY

Biotechnology

A PRODUCT RANI THERAPEUTICS HOLDINGS, INC. IS KNOWN FOR

RaniPill® Capsule
RaniPill® Capsule

The RaniPill® is a clinical-stage, oral robotic pill that painlessly injects biologic drugs into the intestine, with recent positive Phase 1 results for RT-111 and ongoing studies for RT-114.

COMPETITORS

COMPETITOR
ANNX COMPARE
MGTX COMPARE
ORMP COMPARE
PROK COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
19
LISTED HERE
4
RANKED BY POSITION SIZE
VTI
0.00% · 3.6M
BTEE.L
0.01% · 72.1K
IBBQ
0.01% · 6.9K
BIB
0.00% · 4.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
59.68%
HOLDERS
93
TOP 12 OF 93 · RANKED BY POSITION SIZE
Samsara Biocapital, LLC
8.5M sh · $6.25M
Ra Capital Management, L.P.
8.5M sh · $6.25M
Awm Investment Company, Inc.
6.5M sh · $4.78M
Vanguard Group Inc
5.1M sh · $6.9M
Armistice Capital, LLC
3.2M sh · $1.62M
Longaeva Partners L.P.
2.3M sh · $1.71M
Siren, L.L.C.
2.0M sh · $1.47M
Geode Capital Management, LLC
903.3K sh · $664.06K
Blackrock, Inc.
556.9K sh · $409.2K
Nan Fung Group Holdings Ltd
493.6K sh · $362.69K
683 Capital Management, LLC
487.2K sh · $357.97K
Citadel Advisors LLC
452.5K sh · $226.18K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity3
Price To Earnings1
Price To Book2
Overall Score2

INSIDER TRADES

★
DIRECTOR
Gilson Michelle
Purchase · 247.2K shares
2026-08-03
★
DIRECTOR
Gilson Michelle
— · 12.5K shares
2026-08-01
★
DIRECTOR, 10 PERCENT OWNER:
IMRAN MIR A
Purchase · 36.0K shares
2026-07-21
★
OFFICER: CHIEF TECHNICAL OFFICER
Javadi Alireza
Sale · 386 shares
2026-03-27

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
3 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY Canaccord Genuity BUY Maxim Group BUY

SECTORS PEERS

PEERPRICE
TNXP$13.59COMPARE
IPHA$2.22COMPARE
CRBP$10.91COMPARE
MOLN$4.50COMPARE
MIST$1.16COMPARE
CRDF$0.94COMPARE
ELTX$2.84COMPARE